Moderna COVID-19 (6m-5y) Bivalent Booster Vaccine PF Interactions
There are 321 drugs known to interact with Moderna COVID-19 (6m-5y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine). Of the total drug interactions, 1 is major, 317 are moderate, and 3 are minor.
- View all 321 medications that may interact with Moderna COVID-19 (6m-5y) Bivalent Booster Vaccine PF
Most frequently checked interactions
View interaction reports for Moderna COVID-19 (6m-5y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine) and the medicines listed below.
- Abrysvo (rsv vaccine, pref a-pref b, recombinant)
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- acyclovir topical
- Adacel (Tdap) (diphtheria toxoid / pertussis, acellular / tetanus toxoid)
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- albuterol
- albuterol / ipratropium
- Allegra (fexofenadine)
- Allegra-D 12 Hour (fexofenadine / pseudoephedrine)
- Allegra-D 24 Hour Allergy & Congestion (fexofenadine / pseudoephedrine)
- amlodipine
- amoxicillin
- aspirin
- Azithromycin Dose Pack (azithromycin)
- levothyroxine
- loratadine
- magnesium oxide
- Moderna COVID-19 (2023-2024) PF Vaccine (cvx 311) (sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 311))
- Moderna COVID-19 Vaccine (sars-cov-2 (covid-19) mrna-1273 vaccine)
- Nature's Bounty Probiotic (bifidobacterium infantis / lactobacillus acidophilus)
- omeprazole
- Paxlovid (nirmatrelvir / ritonavir)
- pneumococcal 13-valent vaccine
- prednisone
- rosuvastatin
- Shingrix (zoster vaccine, recombinant)
- sildenafil
- turmeric
- Vitamin D3 (cholecalciferol)
More about Moderna COVID-19 (6m-5y) Bivalent Booster Vaccine PF (sars-cov-2 (covid-19) mrna-1273 (6m-5y bivalent booster) vaccine)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.